The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 07, 2019

Filed:

Dec. 08, 2014
Applicants:

Ryan Kendall Pierce, San Francisco, CA (US);

Benjamin Kahn Cline, Palo Alto, CA (US);

Inventors:

Ryan Kendall Pierce, San Francisco, CA (US);

Benjamin Kahn Cline, Palo Alto, CA (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61N 1/365 (2006.01); A61B 5/0215 (2006.01); A61F 2/92 (2013.01); A61F 2/82 (2013.01); A61B 17/3207 (2006.01); A61F 2/88 (2006.01); A61F 2/91 (2013.01); A61M 25/10 (2013.01); A61B 17/12 (2006.01); A61B 18/18 (2006.01); A61F 2/915 (2013.01); A61F 2/06 (2013.01); A61B 17/221 (2006.01); A61B 17/22 (2006.01); A61B 18/00 (2006.01); A61B 18/02 (2006.01); A61N 7/00 (2006.01); A61M 25/06 (2006.01);
U.S. Cl.
CPC ...
A61N 1/36564 (2013.01); A61B 5/0215 (2013.01); A61B 17/1204 (2013.01); A61B 17/12109 (2013.01); A61B 17/12136 (2013.01); A61B 17/320725 (2013.01); A61B 18/1492 (2013.01); A61B 18/1815 (2013.01); A61F 2/82 (2013.01); A61F 2/885 (2013.01); A61F 2/91 (2013.01); A61F 2/92 (2013.01); A61M 25/10 (2013.01); A61B 17/221 (2013.01); A61B 2017/22067 (2013.01); A61B 2018/00011 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00214 (2013.01); A61B 2018/00267 (2013.01); A61B 2018/00345 (2013.01); A61B 2018/00404 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/00994 (2013.01); A61B 2018/0212 (2013.01); A61F 2/915 (2013.01); A61F 2002/068 (2013.01); A61F 2002/825 (2013.01); A61F 2002/91533 (2013.01); A61F 2250/0031 (2013.01); A61M 25/1011 (2013.01); A61M 2025/0681 (2013.01); A61M 2025/1015 (2013.01); A61M 2025/1052 (2013.01); A61N 2007/0043 (2013.01);
Abstract

Devices and methods described herein may, among other uses, favorably cause the activation and/or deactivation of vascular baroreceptors in order to achieve a desired impact on a physiological condition, such as baroreflex-regulated conditions, hypertension, hypotension, nervous system disorders, metabolic disorders, cardiovascular disease, heart failure, cardiac arrhythmia, renal disease, respiratory disease, diabetes, and insulin resistance. The devices and methods may be used in concert with each other and/or other treatments, medications, interventions, or behavioral regimens. They may also be used in concert with devices and methods that perform or assist with assessing or measuring a mammal's blood pressure assessing, measuring, or predicting the impact of the described methods and devices on the patient's condition (including blood pressure), and/or protecting the surrounding anatomy from adverse effects.


Find Patent Forward Citations

Loading…